Development asset linked to SciencePharma in public FDA and regional records.
pharma · Not applicable (submitted trial is a bioequivalence in healthy subjects)
SciencePharma
Sciencepharma Sp. z o.o
SciencePharma drug portfolio — 3 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Warszawa, EU HQ
2004 Founded
99 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Warszawa, EU
- Founded
- 2004
- Employees
- 99
- Programs
- 1
- Drugs
- 3
- Patents
- 0
SciencePharma pipeline
Portfolio lens on 3 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
SciencePharma drug portfolio — 3 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
US regulatory status: approved. Mechanism: Unknown.
- Mechanism
- Unknown
-
Development asset linked to SciencePharma in public FDA and regional records.